Remote Patient Monitoring (RPM) Market Trends and Overview

Remote Patient Monitoring (RPM) Market was valued at USD 51.4 billion in 2022. It is projected to reach USD 354.49 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 27.3% during the forecast period from 2023 to 2030.

Remote Patient Monitoring (RPM) refers to the practice of using technology to monitor patients' health remotely. This innovative approach allows healthcare providers to collect and analyze vital health data without the need for in-person visits. With the increasing adoption of RPM solutions, the market has witnessed significant growth and is expected to continue its upward trajectory in the coming years.

The rapid expansion of the RPM market can be attributed to several factors. Firstly, the growing prevalence of chronic diseases, such as diabetes, cardiovascular disorders, and respiratory conditions, has necessitated the need for continuous monitoring and management. RPM offers a convenient and efficient way to track patients' health parameters, enabling timely interventions and personalized care.

Furthermore, advancements in technology have played a crucial role in driving the adoption of RPM solutions. The development of wearable devices, smart sensors, and mobile applications has made it easier for patients to monitor their health from the comfort of their homes. These devices can track vital signs, medication adherence, and even detect early warning signs of potential health complications.

Moreover, the COVID-19 pandemic has further accelerated the demand for remote patient monitoring. With the need to minimize in-person visits and reduce the risk of exposure, healthcare providers have increasingly turned to RPM solutions to remotely monitor and manage patients. This trend is expected to continue even beyond the pandemic, as the benefits of RPM extend beyond crisis management.

Get Free Sample Report @ https://www.snsinsider.com/sample-request/1788

KEY MARKET SEGMENTATION:

By Component:

• Services & Software
• Devices 
  • Cardiac Monitoring Devices
  • Neurological Monitoring Devices
  • Respiratory Monitoring Devices
  • Blood Glucose Monitoring Devices
  • Weight Monitoring Devices
  • Multiparameter Monitoring Devices
  • Fetal &Neonatal Monitoring Devices
  • Others

By End-Use:

• Providers
  • Hospitals & Clinics
  • Passive Exoskeletons
  • Ambulatory Care Centers
  • Home Care Settings & Long-term Care Centers
  • Others
• Payers
• Patients
• Other End-Users

Some of the major key players are as follows: Abbott, Boston Scientific Corporation, F. Hoffmann-La Roche Ltd, Koninklijke Philips N.V., Nihon Kohden Corporation, Omron Corporation, Smiths Medical, OSI Systems, Inc., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Welch Allyn, and other players.

About US:

SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.

We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.

Contact Us:

Akash Anand — Head of Business Development & Strategy,

[email protected],

Phone: +1–415–230–0044 (US) | +91–7798602273 (IND),

Website: https://www.snsinsider.com